London South East Investor Webinar - with presentations & Q&A from Power, Cora, Zephyr and VRE Watch Now

Less Ads, More Data, More Tools Register for FREE
London South East Investor Webinar - with presentations & Q&A from Power, Cora, Zephyr and VRE
London South East Investor Webinar - with presentations & Q&A from Power, Cora, Zephyr and VREView Video
Cora Gold CEO Bert Monro presented at the London South East Investor Webinar #CORA
Cora Gold CEO Bert Monro presented at the London South East Investor Webinar #CORAView Video

Pin to quick picksAstrazeneca Regulatory News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7,844.00
Bid: 7,844.00
Ask: 7,845.00
Change: 115.00 (1.49%)
Spread: 1.00 (0.01%)
Open: 7,849.00
High: 7,883.00
Low: 7,787.00
Yest. Close: 7,729.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.
Date   Source Headline
11th May 20165:30 pmRNSPublication of Final Terms
9th May 20165:35 pmRNSLaunch and pricing of EUR2.2bn bond issues
5th May 20163:00 pmRNSPublication of a Prospectus
3rd May 20161:30 pmRNSTotal Voting Rights
3rd May 20167:01 amRNSAstraZeneca completes divestment of Imdur
3rd May 20167:00 amRNSAZ COMPLETES ACQUISITION OF TAKEDA RESPIRATORY
29th Apr 20165:30 pmRNSResult of AGM
29th Apr 201612:46 pmRNSPOSITIVE CHMP OPINION FOR CAZ AVI
29th Apr 20167:00 amRNSAZN: 1st Quarter Results
28th Apr 20169:00 amRNSNotice of Results
26th Apr 20169:29 amRNSAZ enters US licensing agreement with Ironwood
26th Apr 20167:01 amRNSBEVESPI AEROSPHERE APPROVED BY US FDA FOR COPD
8th Apr 20167:00 amRNSAZ TO CONTINUE PIVOTAL ALZHEIMER'S CLINICAL TRIAL
1st Apr 201611:30 amRNSTotal Voting Rights
29th Mar 20167:00 amRNSTAGRISSO APPROVED IN JAPAN FOR CANCER PATIENTS
24th Mar 20163:00 pmRNSDirector/PDMR Shareholding
23rd Mar 20167:00 amRNSAZ reports results from Brilinta stroke trial
18th Mar 201610:30 amRNSNotice of AGM
8th Mar 20166:29 pmRNSFiling of Form 20-F with SEC
8th Mar 201612:00 pmRNSAnnual Financial Report
1st Mar 20162:30 pmRNSTotal Voting Rights
29th Feb 20161:45 pmRNSAZ REPORTS TOP-LINE RESULT OF TREMELIMUMAB TRIAL
29th Feb 20167:59 amRNSAZ enters licensing agreement with CMS for Plendil
26th Feb 201612:00 pmRNSDirector/PDMR Shareholding
25th Feb 20168:57 amRNSACALABRUTINIB ORPHAN DRUG DESIGNATION RECOMMENDED
19th Feb 20167:05 amRNSBRILIQUE APPROVED IN EU FOR HEART ATTACK PATIENTS
19th Feb 20167:00 amRNSZURAMPIC APPROVED IN EU FOR GOUT PATIENTS
17th Feb 20167:00 amRNSDurvalumab granted BTD by FDA for cancer patients
16th Feb 20168:01 amRNSNEW EXTERNAL BOARD APPOINTMENT
4th Feb 20167:00 amRNSAstraZeneca Full-Year and Q4 2015 Results
3rd Feb 20169:00 amRNSNotice of Results
3rd Feb 20167:00 amRNSTAGRISSO approved in EU for cancer patients
2nd Feb 20169:05 amRNSAZ Completes transaction with Acerta Pharma
1st Feb 20162:32 pmRNSTotal Voting Rights
28th Jan 20167:00 amRNSLynparza Granted BTD in US for Prostate Cancer
4th Jan 20162:00 pmRNSDirector/PDMR Shareholding
4th Jan 20162:00 pmRNSDirector/PDMR Shareholding
4th Jan 20161:30 pmRNSTotal Voting Rights
23rd Dec 20154:30 pmRNSResult of External Audit Tender
23rd Dec 20157:00 amRNSLESINURAD APPROVED BY US FDA FOR GOUT
18th Dec 201512:41 pmRNSTAGRISSOT (OSIMERTINIB) POSITIVE CHMP OPINION
18th Dec 201512:41 pmRNSBRILIQUE (TICAGRELOR) POSITIVE EU CHMP OPINION
18th Dec 201512:40 pmRNSCHMP ISSUES POSITIVE OPINION ON LESINURAD FOR GOUT
18th Dec 20157:00 amRNSATLANTIC TRIAL SUPPORTS CLINICAL ACTIVITY
17th Dec 20152:08 pmRNSASTRAZENECA COMPLETES ACQUISITION OF ZS PHARMA
17th Dec 20157:00 amRNSAZ INVESTS IN ACERTA PHARMA TO ENHANCE GROWTH
16th Dec 20157:12 amRNSAZ ACQUISITION OF TAKEDA'S RESPIRATORY BUSINESS
15th Dec 20153:06 pmRNSAZ COMPLETES AGREEMENT WITH PERRIGO
14th Dec 20157:56 amRNSDiscussions with Acerta Pharma BV
2nd Dec 20157:00 amRNSLate-Stage Pipeline Conference Call

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.